Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angela Collura"'
Autor:
Karl S. Peggs, Sarah J. Albon, Macarena Oporto Espuelas, Catherine Irving, Rachel Richardson, Joan Casanovas-Company, Rebecca Wallace, Aleks Guvenel, Sara Ghorashian, Angela Collura, Meera Subramaniyam, Barry Flutter, Bilyana Popova, Fernanda Castro, Andre Lopes, Kim Champion, Oliver Schofield, Laura Clifton-Hadley, Thomas Taylor, Maria Farrell, Stuart Adams, Kimberly C. Gilmour, Stephen Mackinnon, Eleni Tholouli, Persis J. Amrolia
Publikováno v:
Cytotherapy. 25:82-93
Delayed immune reconstitution is a major challenge after matched unrelated donor (MUD) stem cell transplant (SCT). In this randomized phase 2 multi-center trial, Adoptive Immunotherapy with CD25/71 allodepleted donor T cells to improve immunity after
Autor:
Angela Collura
Publikováno v:
Cell and Gene Therapy Insights. :1015-1020
Autor:
Karl S. Peggs, Eleni Tholouli, Persis Amrolia, Laura Clifton-Hadley, Catherine Irving, Barry Flutter, Fernanda Castro, Stuart J. Ings, Kim Champion, Joan Casanovas-Company, Aleks Guvenel, Angela Collura, Rachael Wilding, Bilyana Popova, Timothy Pulham, Kimberly Gilmour, Thomas Taylor, Oliver Schofield, Sarah J. Albon, Rebecca Wallace, Andre Lopes, Wendy Ogden, Meera Subramaniyam, Rachel Richardson, Stuart Adams, Robert Herlihy, Stephen Mackinnon, Gulrukh Ahsan, Maria Farrell, Sara Ghorashian
Publikováno v:
Blood. 134:1995-1995
Karl S Peggs and Sarah J Albon contributed equally to the work and are joint first author Introduction Alemtuzumab reduces the incidence of GVHD after unrelated donor stem cell transplant (MUD SCT) but delays immune reconstitution resulting in high m
Autor:
Karen Howe, Gordon Cheung, Rebecca Wallace, Nigel Westwood, Karin Straathof, Thalia Loka, Karen Dyer, Claire Barton, Sarita Depani, Angela Collura, Jack Barton, John Anderson, Talia Gileadi, Simon Thomas, Sarah Inglott, Gary Wright, David P. Edwards, Barry Flutter, Giuseppe Barone, Martin Pule
Publikováno v:
Cancer Research. 78:CT145-CT145
Background: Treatment of high risk neuroblastoma remains challenging; current multimodal treatment regimens achieve long term survival in Trial design: The therapeutic (1RG-CART) is autologous T-cells transduced with a gamma-retroviral vector encodin